A study published in July 2025 issue of Journal of Neurology explored how genetic variability in the FCGR2/3 locus, which ...

Guillain-Barre syndrome has gained attention due to a possible link with COVID-19. Experts what the disease is as well as causes, symptoms and treatment.

A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus.

"Our in-vitro and in-vivo experiments show that the RCC1 variants associated with axonal neuropathy in children alter ...

A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

Guillain-Barré syndrome (GBS) is a rare, autoimmune disease that sees the body's own immune system damages the nerves. It causes muscle weakness and sometimes paralysis, the U.S. Centers for ...

Annexon offers speculative upside with Tanruprubart, targeting Guillain-Barré Syndrome's unmet needs. Click here to read my ...

Guillain-Barré Syndrome (GBS), a rare autoimmune condition, has claimed another life in Pune, Maharashtra. Earlier this week, the state reported the first death, sharing that the number of cases ...

A Houston woman who developed the rare neurological condition Guillain-Barré syndrome (GBS) after receiving the one-dose Johnson & Johnson COVID-19 vaccine said she would get the shot again ...

Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long ...

Mallory Wilkerson woke up to a strange tingling in her hands and feet — like they had fallen asleep overnight. Not long after, she was diagnosed with Guillain-Barré Syndrome (GBS).

Guillain-Barré syndrome, sometimes called GBS, is an autoimmune disorder in which the body's immune system attacks the nerves, causing muscle weakness and occasionally paralysis.